Literature DB >> 24450648

Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer.

Belinda Hall1, Rachel Simmonds1.   

Abstract

Mycolactone is a polyketide macrolide lipid-like secondary metabolite synthesized by Mycobacterium ulcerans, the causative agent of BU (Buruli ulcer), and is the only virulence factor for this pathogen identified to date. Prolonged exposure to high concentrations of mycolactone is cytotoxic to diverse mammalian cells (albeit with varying efficiency), whereas at lower doses it has a spectrum of immunosuppressive activities. Combined, these pleiotropic properties have a powerful influence on local and systemic cellular function that should explain the pathophysiology of BU disease. The last decade has seen significant advances in our understanding of the molecular mechanisms underlying these effects in a range of different cell types. The present review focuses on the current state of our knowledge of mycolactone function, and its molecular and cellular targets, and seeks to identify commonalities between the different functional and cellular systems. Since mycolactone influences fundamental cellular processes (cell division, cell death and inflammation), getting to the root of how mycolactone achieves this could have a profound impact on our understanding of eukaryotic cell biology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24450648     DOI: 10.1042/BST20130133

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  22 in total

1.  Mycolactone Toxin Membrane Permeation: Atomistic versus Coarse-Grained MARTINI Simulations.

Authors:  Fikret Aydin; Rui Sun; Jessica M J Swanson
Journal:  Biophys J       Date:  2019-05-21       Impact factor: 4.033

2.  Biochemical and Biological Assays of Mycolactone-Mediated Inhibition of Sec61.

Authors:  Sarah O'Keefe; Stephen High; Caroline Demangel
Journal:  Methods Mol Biol       Date:  2022

3.  Responses to chemical cross-talk between the Mycobacterium ulcerans toxin, mycolactone, and Staphylococcus aureus.

Authors:  Laxmi Dhungel; Lindsey Burcham; Joo Youn Park; Harshini Devi Sampathkumar; Albert Cudjoe; Keun Seok Seo; Heather Jordan
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

4.  Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon.

Authors:  Miriam Bolz; Martin W Bratschi; Sarah Kerber; Jacques C Minyem; Alphonse Um Boock; Moritz Vogel; Pierre Franklin Bayi; Thomas Junghanss; Daniela Brites; Simon R Harris; Julian Parkhill; Gerd Pluschke; Araceli Lamelas Cabello
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

5.  Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.

Authors:  Bryan E Hart; Laura P Hale; Sunhee Lee
Journal:  PLoS Negl Trop Dis       Date:  2015-09-22

Review 6.  Macrophage cytokines: involvement in immunity and infectious diseases.

Authors:  Guillermo Arango Duque; Albert Descoteaux
Journal:  Front Immunol       Date:  2014-10-07       Impact factor: 7.561

Review 7.  Bacterial Toxins as Pathogen Weapons Against Phagocytes.

Authors:  Ana do Vale; Didier Cabanes; Sandra Sousa
Journal:  Front Microbiol       Date:  2016-02-01       Impact factor: 5.640

8.  The untapped cell biology of neglected tropical diseases.

Authors:  William Sullivan
Journal:  Mol Biol Cell       Date:  2016-03-01       Impact factor: 4.138

9.  Metabolomic profiles delineate mycolactone signature in Buruli ulcer disease.

Authors:  Fatoumata Niang; Fred S Sarfo; Michael Frimpong; Laure Guenin-Macé; Mark Wansbrough-Jones; Timothy Stinear; Richard O Phillips; Caroline Demangel
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

10.  The pathogenic mechanism of the Mycobacterium ulcerans virulence factor, mycolactone, depends on blockade of protein translocation into the ER.

Authors:  Belinda S Hall; Kirsti Hill; Michael McKenna; Joy Ogbechi; Stephen High; Anne E Willis; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2014-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.